EPO published patent EP4332839A2 granting Bioverativ Therapeutics Inc. intellectual property rights over population pharmacokinetics modeling tools and uses thereof. The patent, filed by inventor Haiyan JIANG, covers computational systems using G06N 7/01 (probabilistic computing) combined with G16C 20/30 (computational chemistry), G16C 20/70 (cheminformatics), and G16H 20/10 (ICT for therapies) classifications. Designated states include all major EU member states plus EPO extension states.

Pharmaceutical companies and biotech firms developing pharmacokinetics modeling software or drug dosing optimization tools should review this patent to assess potential licensing needs or freedom-to-operate considerations. The patent does not impose compliance obligations but establishes enforceable IP rights that may affect research and development activities in the pharmaceutical modeling space.